Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.306 USD | -4.49% | -5.11% | -94.12% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.12% | 19.53M | |
+47.73% | 57.87B | |
+41.65% | 40.25B | |
-6.99% | 39.94B | |
-5.96% | 28.54B | |
+12.04% | 26.4B | |
-20.52% | 19.33B | |
+30.17% | 12.4B | |
-0.73% | 12.23B | |
+23.91% | 12.2B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics Says Phase 2 Trial for Chronic Rhinosinusitis Treatment Meets Primary Endpoint